Skip to main content
Signal8

Luderer Albert

SEC insider (Form 3/4/5 filer). CIK 0001746822. Interim Chief Executive at Bionano Genomics, Inc. (BNGO). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2026. Located in SAN DIEGO, CA.

Companies Luderer Albert has filed insider reports for

  • Bionano Genomics, Inc. (BNGO): Director, Officer, Interim Chief Executive
Luderer Albert profile photo

Luderer Albert

CIK: 0001746822

Transaction Breakdown

Open Market Buys (P)2 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Bionano Genomics, Inc. logo
BNGO

Bionano Genomics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Sep 4, 2026
    Purchase
    Indirect
    4K shares at avg. $1.21$5K
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Aug 21, 2026
    Purchase
    Indirect
    4K shares at avg. $1.22$5K
  • Bionano Genomics, Inc. logo
    BNGO

    Bionano Genomics, Inc.

    Jun 11, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    2.8K shares-

1-3 of 3